Is Axogen Stock a Good Investment?
Axogen Investment Advice | AXGN |
- Examine Axogen's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Axogen's leadership team and their track record. Good management can help Axogen navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Axogen's business and its evolving consumer preferences.
- Compare Axogen's performance and market position to its competitors. Analyze how Axogen is positioned in terms of product offerings, innovation, and market share.
- Check if Axogen pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Axogen's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Axogen Inc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Axogen Inc is a good investment.
Sell | Buy |
Strong Buy
Market Performance | Modest | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Axogen Stock
Researching Axogen's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company recorded a loss per share of 0.23. Axogen Inc last dividend was issued on the 27th of January 2010. The entity had 105:100 split on the 11th of July 1994.
To determine if Axogen is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Axogen's research are outlined below:
| Axogen Inc had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 187.34 M. Net Loss for the year was (9.96 M) with profit before overhead, payroll, taxes, and interest of 141.98 M. | |
| Latest headline from news.google.com: Disposition of 15111 shares by Erick DeVinney of Axogen at 17.5 subject to Rule 16b-3 |
Axogen uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Axogen Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Axogen's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Axogen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Axogen's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-05-02 | 2024-03-31 | -0.07 | -0.06 | 0.01 | 14 | ||
2020-02-24 | 2019-12-31 | -0.09 | -0.1 | -0.01 | 11 | ||
2018-02-28 | 2017-12-31 | -0.08 | -0.07 | 0.01 | 12 | ||
2017-05-04 | 2017-03-31 | -0.1 | -0.11 | -0.01 | 10 | ||
2017-08-02 | 2017-06-30 | -0.08 | -0.06 | 0.02 | 25 | ||
2017-02-22 | 2016-12-31 | -0.08 | -0.1 | -0.02 | 25 | ||
2015-11-05 | 2015-09-30 | -0.13 | -0.11 | 0.02 | 15 | ||
2012-11-07 | 2012-09-30 | -0.18 | -0.2 | -0.02 | 11 |
Axogen Target Price Consensus
Axogen target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Axogen's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 6 | Strong Buy |
Most Axogen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Axogen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Axogen Inc, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationAxogen Target Price Projection
Axogen's current and average target prices are 18.04 and 18.50, respectively. The current price of Axogen is the price at which Axogen Inc is currently trading. On the other hand, Axogen's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Axogen Target Price
Axogen Analyst Ratings
Axogen's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Axogen stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Axogen's financials, market performance, and future outlook by experienced professionals. Axogen's historical ratings below, therefore, can serve as a valuable tool for investors.Know Axogen's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Axogen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Axogen Inc backward and forwards among themselves. Axogen's institutional investor refers to the entity that pools money to purchase Axogen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Dimensional Fund Advisors, Inc. | 2024-12-31 | 772.8 K | Armistice Capital, Llc | 2024-12-31 | 613 K | Deutsche Bank Ag | 2024-12-31 | 594.8 K | Tocqueville Asset Management L.p. | 2024-12-31 | 589.9 K | Silvercrest Asset Management Group Llc | 2024-12-31 | 583.6 K | D. E. Shaw & Co Lp | 2024-12-31 | 488.3 K | Prudential Financial Inc | 2024-12-31 | 418.3 K | Charles Schwab Investment Management Inc | 2024-12-31 | 416.6 K | Bank Of America Corp | 2024-12-31 | 402.5 K | First Light Asset Management, Llc | 2024-12-31 | 4.5 M | Blackrock Inc | 2024-12-31 | 3.4 M |
Axogen's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 793.75 M.Market Cap |
|
Axogen's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.05) | (0.05) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.05) | (0.05) | |
| Return On Equity | (0.10) | (0.10) |
Determining Axogen's profitability involves analyzing its financial statements and using various financial metrics to determine if Axogen is a good buy. For example, gross profit margin measures Axogen's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Axogen's profitability and make more informed investment decisions.
Evaluate Axogen's management efficiency
Axogen Inc has return on total asset (ROA) of (0.0103) % which means that it has lost $0.0103 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0999) %, meaning that it created substantial loss on money invested by shareholders. Axogen's management efficiency ratios could be used to measure how well Axogen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 20th of March 2025, Return On Tangible Assets is likely to drop to -0.05. In addition to that, Return On Capital Employed is likely to grow to -0.02. At this time, Axogen's Asset Turnover is very stable compared to the past year.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.35 | 1.50 | |
| Tangible Book Value Per Share | 2.22 | 1.45 | |
| Enterprise Value Over EBITDA | 126.75 | 133.09 | |
| Price Book Value Ratio | 7.02 | 12.77 | |
| Enterprise Value Multiple | 126.75 | 133.09 | |
| Price Fair Value | 7.02 | 12.77 | |
| Enterprise Value | 770.5 M | 809 M |
At Axogen Inc, effective management practices are pivotal to sustaining long-term profitability. We delve into financial metrics and market conditions to provide a comprehensive analysis of the stock's prospects.
Beta 1.022 |
Basic technical analysis of Axogen Stock
As of the 20th of March, Axogen shows the Mean Deviation of 2.68, risk adjusted performance of 0.0875, and Downside Deviation of 2.63. Axogen Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Axogen's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Axogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Axogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Axogen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Axogen's Outstanding Corporate Bonds
Axogen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Axogen Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Axogen bonds can be classified according to their maturity, which is the date when Axogen Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US05464HAB69 Corp BondUS05464HAB69 | View | |
| AXIS SPECIALTY FIN Corp BondUS05464HAC43 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| US05463HAB78 Corp BondUS05463HAB78 | View | |
| US05463HAC51 Corp BondUS05463HAC51 | View | |
| US05465CAA80 Corp BondUS05465CAA80 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View |
Understand Axogen's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Axogen's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0875 | |||
| Market Risk Adjusted Performance | 0.4281 | |||
| Mean Deviation | 2.68 | |||
| Semi Deviation | 2.46 | |||
| Downside Deviation | 2.63 | |||
| Coefficient Of Variation | 1113.2 | |||
| Standard Deviation | 3.97 | |||
| Variance | 15.78 | |||
| Information Ratio | 0.1062 | |||
| Jensen Alpha | 0.4089 | |||
| Total Risk Alpha | 0.6821 | |||
| Sortino Ratio | 0.1603 | |||
| Treynor Ratio | 0.4181 | |||
| Maximum Drawdown | 21.8 | |||
| Value At Risk | (3.56) | |||
| Potential Upside | 5.97 | |||
| Downside Variance | 6.92 | |||
| Semi Variance | 6.05 | |||
| Expected Short fall | (3.74) | |||
| Skewness | 1.75 | |||
| Kurtosis | 6.48 |
| Risk Adjusted Performance | 0.0875 | |||
| Market Risk Adjusted Performance | 0.4281 | |||
| Mean Deviation | 2.68 | |||
| Semi Deviation | 2.46 | |||
| Downside Deviation | 2.63 | |||
| Coefficient Of Variation | 1113.2 | |||
| Standard Deviation | 3.97 | |||
| Variance | 15.78 | |||
| Information Ratio | 0.1062 | |||
| Jensen Alpha | 0.4089 | |||
| Total Risk Alpha | 0.6821 | |||
| Sortino Ratio | 0.1603 | |||
| Treynor Ratio | 0.4181 | |||
| Maximum Drawdown | 21.8 | |||
| Value At Risk | (3.56) | |||
| Potential Upside | 5.97 | |||
| Downside Variance | 6.92 | |||
| Semi Variance | 6.05 | |||
| Expected Short fall | (3.74) | |||
| Skewness | 1.75 | |||
| Kurtosis | 6.48 |
Consider Axogen's intraday indicators
Axogen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Axogen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Axogen Corporate Filings
F4 | 19th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 4th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10K | 26th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
| 3rd of February 2025 Other Reports | ViewVerify |
Axogen Stock media impact
Far too much social signal, news, headlines, and media speculation about Axogen that are available to investors today. That information is available publicly through Axogen media outlets and privately through word of mouth or via Axogen internal channels. However, regardless of the origin, that massive amount of Axogen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Axogen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Axogen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Axogen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Axogen alpha.
Axogen Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Axogen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Axogen Corporate Executives
Elected by the shareholders, the Axogen's board of directors comprises two types of representatives: Axogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Axogen. The board's role is to monitor Axogen's management team and ensure that shareholders' interests are well served. Axogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Axogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter Mariani | Ex CFO | Profile |
Already Invested in Axogen Inc?
The danger of trading Axogen Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Axogen is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Axogen. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Axogen Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Axogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axogen Inc Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.23) | Revenue Per Share | Quarterly Revenue Growth 0.151 | Return On Assets | Return On Equity |
The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Axogen's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.